Cutaneous scars in American tegumentary leishmaniasis patients: a site of Leishmania (Viannia) braziliensis persistence and viability eleven years after antimonial therapy and clinical cure
- PMID: 9660473
- DOI: 10.4269/ajtmh.1998.58.824
Cutaneous scars in American tegumentary leishmaniasis patients: a site of Leishmania (Viannia) braziliensis persistence and viability eleven years after antimonial therapy and clinical cure
Abstract
Two former patients treated for the cutaneous form of American tegumentary leishmaniasis were reviewed eight and 11 years, respectively, following clinical cure. We were able to isolate Leishmania parasites in a culture of material from the two scar biopsies, and in one of them the parasite was characterized as Leishmania (Viannia) braziliensis. In both cases, the histopathology revealed discreet hyperceratosis and a slight infiltrate of mononuclear cells surrounding and on the walls of the surface and deep dermal vessels. No amastigotes were seen on immunohistochemical or histopathologic examination. The Montenegro skin test result and the in vitro lymphoproliferative response to Leishmania antigen were positive, but no specific IgG and IgM antibodies were detected. Otorhinolaryngologic examination showed no macroscopic alteration in the mucosae. These findings are important for the evaluation and criteria of post-treatment cure.
Similar articles
-
Persistence of leishmania parasites in scars after clinical cure of American cutaneous leishmaniasis: is there a sterile cure?J Infect Dis. 2004 Mar 15;189(6):1018-23. doi: 10.1086/382135. Epub 2004 Mar 2. J Infect Dis. 2004. PMID: 14999605
-
[Effect of intralesional treatment with emetine hydrochloride on Leishmania (Viannia) braziliensis in hamsters].Invest Clin. 2001 Mar;42(1):5-21. Invest Clin. 2001. PMID: 11294031 Spanish.
-
Sensitivity of Leishmania braziliensis promastigotes to meglumine antimoniate (glucantime) is higher than that of other Leishmania species and correlates with response to therapy in American tegumentary leishmaniasis.J Parasitol. 2007 Jun;93(3):688-93. doi: 10.1645/GE-1031R.1. J Parasitol. 2007. PMID: 17626365
-
Zosteriform cutaneous leishmaniasis due to Leishmania ( Viannia ) panamensis and Leishmania ( Viannia ) braziliensis: report of three cases.Biomedica. 2014 Jul-Sep;34(3):340-4. doi: 10.1590/S0120-41572014000300004. Biomedica. 2014. PMID: 25504121
-
Persistent infections by Leishmania (Viannia) braziliensis.Mem Inst Oswaldo Cruz. 1997 May-Jun;92(3):333-8. doi: 10.1590/s0074-02761997000300006. Mem Inst Oswaldo Cruz. 1997. PMID: 9332597 Review.
Cited by
-
Intralesional meglumine antimoniate for treatment of cutaneous leishmaniasis patients with contraindication to systemic therapy from Rio de Janeiro (2000 to 2006).Am J Trop Med Hyg. 2012 Aug;87(2):257-60. doi: 10.4269/ajtmh.2012.11-0612. Am J Trop Med Hyg. 2012. PMID: 22855754 Free PMC article.
-
Characterization of Leishmania spp. causing cutaneous leishmaniasis in Manaus, Amazonas, Brazil.Parasitol Res. 2011 Mar;108(3):671-7. doi: 10.1007/s00436-010-2139-9. Epub 2010 Nov 12. Parasitol Res. 2011. PMID: 21072540 Free PMC article.
-
Risk factors for therapeutic failure to meglumine antimoniate and miltefosine in adults and children with cutaneous leishmaniasis in Colombia: A cohort study.PLoS Negl Trop Dis. 2017 Apr 5;11(4):e0005515. doi: 10.1371/journal.pntd.0005515. eCollection 2017 Apr. PLoS Negl Trop Dis. 2017. PMID: 28379954 Free PMC article.
-
Persistence of L. V. braziliensis in the Nasal Mucosa of Treated Patients.Biomedicines. 2025 Jul 3;13(7):1634. doi: 10.3390/biomedicines13071634. Biomedicines. 2025. PMID: 40722705 Free PMC article.
-
Tracking of quiescence in Leishmania by quantifying the expression of GFP in the ribosomal DNA locus.Sci Rep. 2019 Dec 12;9(1):18951. doi: 10.1038/s41598-019-55486-z. Sci Rep. 2019. PMID: 31831818 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical